Arrowstreet Capital, Limited Partnership Royalty Pharma PLC Transaction History

Arrowstreet Capital, Limited Partnership

$121 Billion
Q3 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Royalty Pharma PLC stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 1,390,223 shares of RPRX stock, worth $33.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,390,223

Previous 940,034 47.89%

Holding current value

$33.8 Million

Previous $24.8 Million 58.66%

% of portfolio

0.03%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$25.63 - $29.27 $11.5 Million - $13.2 Million	450,189 Added 47.89%	1,390,223 $39.3 Million
Q2 2024 Aug 14, 2024	BUY	$26.26 - $29.9 $1.5 Million - $1.71 Million	57,288 Added 6.49%	940,034 $24.8 Million
Q1 2024 May 15, 2024	SELL	$27.46 - $31.33 $24.6 Million - $28.1 Million	-896,490 Reduced 50.39%	882,746 $26.8 Million
Q4 2023 Feb 14, 2024	SELL	$26.21 - $29.22 $4.56 Million - $5.08 Million	-174,006 Reduced 8.91%	1,779,236 $50 Million
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $1.02 Million - $1.22 Million	39,026 Added 2.04%	1,953,242 $53 Million
Q2 2023 Aug 14, 2023	SELL	$29.6 - $36.56 $1.24 Million - $1.53 Million	-41,909 Reduced 2.14%	1,914,216 $58.8 Million
Q1 2023 May 15, 2023	SELL	$32.77 - $39.4 $17.8 Million - $21.4 Million	-542,745 Reduced 21.72%	1,956,125 $70.5 Million
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $22.6 Million - $25.4 Million	577,444 Added 30.05%	2,498,870 $98.8 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $34.5 Million - $38.6 Million	864,871 Added 81.86%	1,921,426 $77.2 Million
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $17.4 Million - $20.5 Million	464,078 Added 78.33%	1,056,555 $44.4 Million
Q1 2022 May 13, 2022	BUY	$37.46 - $42.44 $22.2 Million - $25.1 Million	592,477 New	592,477 $23.1 Million
Q4 2021 Feb 14, 2022	SELL	$35.17 - $42.48 $2.09 Million - $2.52 Million	-59,330 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$36.14 - $42.24 $2.14 Million - $2.51 Million	59,330 New	59,330 $2.14 Million
Q2 2021 Aug 13, 2021	SELL	$39.85 - $46.63 $713,315 - $834,677	-17,900 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$42.34 - $52.82 $757,886 - $945,478	17,900 New	17,900 $781,000
Q4 2020 Feb 12, 2021	SELL	$36.12 - $50.05 $10.6 Million - $14.7 Million	-294,481 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$38.56 - $48.36 $11.4 Million - $14.2 Million	294,481 New	294,481 $12.4 Million

Others Institutions Holding RPRX

# of Institutions

413

Shares Held

283M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Royalty Pharma PLC Transaction History